Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

NCT01140425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-00232798
DRUG: PF-00232798
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Pfizer

Collaborators

[object Object]